BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9742499)

  • 21. Hepatocellular carcinoma: surgical treatment options.
    Gonzalez KB; Woodall M
    Nurs Clin North Am; 2001 Sep; 36(3):593-602, xii. PubMed ID: 11532672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma screening.
    JNMA J Nepal Med Assoc; 2008; 47(171):II-III. PubMed ID: 19079369
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 24. Occurrence of hepatocellular carcinoma in nonfibrotic livers.
    Bioulac-Sage P; Le Bail BL; Winnock M; Balabaud C; Bemard C; Blanc JF; Saric J
    Hepatology; 2000 Dec; 32(6):1411-2. PubMed ID: 11186870
    [No Abstract]   [Full Text] [Related]  

  • 25. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epidemiology and diagnosis of hepatocellular carcinomas in cirrhosis].
    Duvoux C
    Ann Chir; 1998; 52(6):511-7. PubMed ID: 9752500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Scrutiny and management of a patient with hepatocarcinoma].
    Mondragón Sánchez R; Echeverría Miranda CA; Gómez Gómez E
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():69-70. PubMed ID: 17471865
    [No Abstract]   [Full Text] [Related]  

  • 30. An unusual presentation of hepatocellular carcinoma: case report and review.
    Silverstein N; Forouhar F; Rossi L; Aziz K
    Conn Med; 2005 Mar; 69(3):133-8. PubMed ID: 15861998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular cancer.
    Whittle DO; Roberts L
    West Indian Med J; 2009 Jun; 58(3):273-6. PubMed ID: 20043538
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatocellular carcinoma: latest developments.
    Walzer N; Kulik LM
    Curr Opin Gastroenterol; 2008 May; 24(3):312-9. PubMed ID: 18408459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCC surveillance: who is the target population?
    Bruix J; Llovet JM
    Hepatology; 2003 Mar; 37(3):507-9. PubMed ID: 12601346
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of risk factors for metabolic syndrome and non-alcoholic fatty liver disease on the progression and prognosis of hepatocellular carcinoma.
    Takamatsu S; Noguchi N; Kudoh A; Nakamura N; Kawamura T; Teramoto K; Igari T; Arii S
    Hepatogastroenterology; 2008; 55(82-83):609-14. PubMed ID: 18613418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
    Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
    García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V
    Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma: overcoming challenges in disease management.
    Gish RG
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):252-61. PubMed ID: 16527686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relief to the scourge of primary hepatocellular carcinoma.
    Ola SO
    Niger J Med; 2002; 11(4):156-60. PubMed ID: 12955991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autoimmune hepatitis: news about a disease on the rise].
    Zenouzi R; Hartl J; Lohse AW
    Dtsch Med Wochenschr; 2014 Oct; 139(40):2020-2. PubMed ID: 25325379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.